At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
Muse S™ Headband systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Benefit of Mindfulness-Based Intervention Using A Wearable Wellness Brain Sensing Device (Muse-S™) in the Treatment of Post-Covid Symptoms
In Brief
A clinical study evaluating Muse S™ Headband system for COVID-19 and Post Acute Sequelae of SARS-CoV-2. Completed, enrolled 45 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the feasibility of using a wearable brain-sensing wellness device (Muse-S) to potentially reduce stress and anxiety during Post-Covid, which is characterized by increased stress and anxiety.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19, Post Acute Sequelae of SARS-CoV-2
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJan 2022
Enrollment StartJun 2022
Primary CompletionNov 2024
Study CompletionDec 2024
TodayJul 2026
First PostedJan 20, 2022
Enrollment StartJun 1, 2022
Primary CompletionNov 30, 2024
Study CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 4.5 years ago
Interventions
Muse S™ Headband systemdevice
Clinical grade, headband style, wireless EEG (electroencephalogram is a test used to evaluate the electrical activity in the brain) system and designed to interact with a mobile device (smartphone or tablet).